Dr. Stephanie Adamczak, MD

Dr. Adamczak practices at Gulf Coast Medical Center in Fort Myers, Florida, part of Lee Health System.

Dr. Adamczak's NPI, 1811300148, was assigned on June 4, 2014. Dr. Adamczak graduated from University of Miami, Lm Miller School of Medicine in 2014. Dr. Adamczak holds Florida license ME156247.

Dr. Adamczak's primary practice is Gulf Coast Medical Center, at 13681 Doctors Way, Fort Myers, FL 33912 in Lee County. The practice phone is (239) 343-1000.

Dr. Adamczak's primary practice is Gulf Coast Medical Center in Fort Myers, Florida, part of Lee Health System. Dr. Adamczak is also affiliated with Lee Memorial Hospital. The medical group on file is Lee Physician Group. Dmand AI also links Dr. Adamczak to 2 more hospitals, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adamczak practices, 8 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Adamczak's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Adamczak is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Adamczak is licensed in Florida.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Adamczak treats.

CMS data shows 731 Medicare services from Dr. Adamczak across 22 procedure codes in 2024, for 286 Medicare patients. Medicare paid $127,876 for them.

CMS counts 286 Medicare patients who saw Dr. Adamczak in 2024. The largest group is 75 to 84, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adamczak's median patient age at 71, with 55% women.

In 2024, Dr. Adamczak wrote 37 Medicare Part D claims for 19 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $123 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

Dr. Adamczak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of spinal fusion by Dr. Adamczak, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Adamczak, published from 2012 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Inflammasomes. Dr. Adamczak has published most often in Conserv Physiol. Dr. Adamczak's most frequent co-authors are Juan Carlos De Rivero Vaccari, MD, PhD, Ndi Geh, MD and Dimitri Laurent, MD.

CMS Open Payments shows 118 general payments to Dr. Adamczak from 17 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 69% of the total. Globus Medical, Inc. paid the most, $2,177.

Dr. Adamczak graduated from University of Miami, Lm Miller School of Medicine in 2014. Dr. Adamczak is a member of CNS.

Dr. Adamczak is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.